EPO and cancer: It was shown that cancer, via inhibition of erythropoietin secretion causes reduced survival and proliferation of erythroid progenitor cells in special areas of the liver and kidney that decreased erythrocytes lifetime and induced anemia (Duncan et al., 1994 ▶).